Mic: How aging can affect what you eat and drink
UC digestive diseases expert discusses aging and its impact on food allergies and intolerance
Mic journalist Tiffany Onyejiaka examined how our digestive systems along with our bodies evolve each year affecting our diet. Digestive conditions like acid reflux, constipation, and lactose intolerance can become much more common as we go through adulthood. Onyejiaka spoke with Loren Brook, MD, assistant professor in the UC College of Medicine Division of Digestive Diseases about how our tolerance to certain foods changes over time.
Loren Brook, MD
Some differences naturally happen as we leave our teenage years behind while others happen not directly because of aging, but because of lifestyle and environmental changes we inevitably experience. “Food allergies or intolerances that we had when we’re younger may actually go away as we age,” explains Brook, also a UC Health gastroenterologist. “If you had an allergy as a kid and want to know if it's still present, consult with a doctor to find out — DIY “tests” are not the best move.”
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
University of Cincinnati graduate programs rise in national rankings across high-demand fields
May 13, 2026
University of Cincinnati graduate programs climbed in the latest U.S. News & World Report rankings, led by strong gains in workforce-focused fields including public health, clinical psychology and business.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.